CDSCO releases 2026 list of new dental antibiotics, anesthetics and antivirals

The Central Drugs Standard Control Organisation (CDSCO) has approved a new cohort of dental drugs for 2026, including several antibiotics, local anesthetics and antivirals. These approvals expand the therapeutic options available to dentists in India, offering newer agents with improved efficacy and safety profiles. Dosage and administration details are provided in the CDSCO approval documents. The drugs are now available for prescription in India and can be incorporated into routine dental practice for infection control, pain management and antiviral prophylaxis.